The most investigated gene-specific methylation biomarkers were RASSF1A, BRCA1, and OPCML, all being tumor-suppressor genes previously reported to be involved in tumorigenesis and methylated in multiple solid cancers [57–60]. The gene discussed is BRCA1; the disease is neoplasm.